The goal of the Molecular Biology and Next Generation Technologies (MBNGT) Core has been, and will continue to be, to provide essential molecular biology and genetic services in advanced technology areas, and to pioneer new areas of research that promote discovery, hypothesis-driven science and innovation to investigators in the Liver Research Center (LRC).
The specific aims of the MBNGT Core are predominantly two-fold. (1) To continue to provide basic services through the availability of dedicated space in the LRC with shared equipment unavailable in individual investigators laboratories. In addition, the Core Manager will continue to provide individualized teaching and service to facilitate the adaptation of molecular genetic assays and procedures to the wide spectrum of students, postdoctoral fellows, residents, fellows, physician-scientists and principle investigators incorporating these assays into their research. (2) To introduce new services primarily related to the dynamic technologies being rapidly employed in research based on massively parallel sequencing (aka. Next Generation Sequencing (NGS)) and advances in bioinformatics. The MBNGT Core will provide teaching and services allowing LRC scientists to access NGS through preparation of specialized libraries, isolation of exosomes and microRNA for deep sequencing and characterization of the microbiome. The close proximity of the MBNGT facility and the availability of staff to teach, advise experimental approaches, perform highly technical procedures and help interpret complex data sets will serve to enrich the research performed in the LRC.
It is estimated that over 30 million Americans have a liver disorder;further, liver disease is one of the ten leading causes of death in the United States. Although advances have been made in diagnosis and treatment of liver diseases, there is still much to be learned. The Liver Research Center at Einstein provides a multidisciplinary approach to the study of liver disease by integrating basic and clinical research efforts to foster development of new insights and paradigms.
| Dulyaninova, Natalya G; Ruiz, Penelope D; Gamble, Matthew J et al. (2018) S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol Biol Cell 29:632-642 |
| Kakabadze, Zurab; Kakabadze, Ann; Chakhunashvili, David et al. (2018) Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure. Hepatology 67:1956-1969 |
| Rao, Lu; Hülsemann, Maren; Gennerich, Arne (2018) Combining Structure-Function and Single-Molecule Studies on Cytoplasmic Dynein. Methods Mol Biol 1665:53-89 |
| Gong, Zhenwei; Tasset, Inmaculada; Diaz, Antonio et al. (2018) Humanin is an endogenous activator of chaperone-mediated autophagy. J Cell Biol 217:635-647 |
| Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4 |
| Caballero, Benjamin; Wang, Yipeng; Diaz, Antonio et al. (2018) Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell 17: |
| Akiyama, Matthew J; Agyemang, Linda; Arnsten, Julia H et al. (2018) Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy. BMC Infect Dis 18:74 |
| Willis, Ian M (2018) Maf1 phenotypes and cell physiology. Biochim Biophys Acta Gene Regul Mech 1861:330-337 |
| Wang, Tony Y; Portincasa, Piero; Liu, Min et al. (2018) Mouse models of gallstone disease. Curr Opin Gastroenterol 34:59-70 |
| Hodge, Dayle Q; Cui, Jihong; Gamble, Matthew J et al. (2018) Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition. Sci Rep 8:841 |
Showing the most recent 10 out of 451 publications
